Enrolling by invitationNCT06376279

Genetic Diagnosis in Inborn Errors of Metabolism

Studying Leber hereditary optic neuropathy

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Region Stockholm
Principal Investigator: Anna Wedell
Karolinska University Hospital, Karolinska Institutet
Intervention: IEM-EP(genetic)
Enrollment: 1000 enrolled
Eligibility: All sexes
Timeline: 2008 – 2030

Collaborators

Karolinska Institutet

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06376279 on ClinicalTrials.gov

Other trials for Leber hereditary optic neuropathy

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE3NCT07406854
A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation
Wuhan Neurophth Biotechnology Limited Company
ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05293626
Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations
Neurophth Therapeutics Inc
RECRUITINGNANCT06682819
Metabolomics Analysis According to the Retinal Nerve Fiber Layer in Patients With NOHL Mutations (MétabOCT)
Hôpital Necker-Enfants Malades

See all trials for Leber hereditary optic neuropathy →

← Back to all trials